Takeda Pharmaceuticals

Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is committed to strive toward better health for people worldwide through leading innovation in medicine. It is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company and one with a 230-year heritage. Takeda’s U.S. clinical development activities are conducted via Takeda Development Center Americas, Inc.

The respective companies currently market metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology and general medicine products and seek to bring further innovation in these areas through a robust development pipeline.

Our mission is simple and compelling: we are committed to strive toward better health for people worldwide through leading innovation in medicine. Our commitment to improving health and supporting our employees, partners and the larger community gives us the purpose to build on the tremendous success we enjoy as an emerging global leader in the pharmaceutical industry.